Disruption of bone marrow stromal cell function by etoposide

Area of Science:

• Hematology
• Immunology
• Cell Biology

Background:

• Long-term hematopoietic reconstitution after chemotherapy and transplantation can be impaired.
• Damage to the bone marrow microenvironment may contribute to these reconstitution deficits.
• Delayed immune system recovery suggests microenvironmental disruption, even with healthy progenitor cells.

Purpose of the Study:

• To evaluate functional changes in bone marrow stromal cells after in vitro exposure to etoposide (VP-16).
• To determine if chemotherapy affects the stromal cell capacity to support immune cell proliferation.
• To investigate the impact of etoposide on VCAM-1 expression in bone marrow stromal cells.

Main Methods:

• Primary human bone marrow stromal cells and a murine stromal cell line (S10) were cultured.
• Cells were exposed in vitro to the chemotherapeutic agent etoposide (VP-16).
• Functional support for lymphoid and myeloid cell proliferation was assessed.
• Vascular cell adhesion molecule-1 (VCAM-1) expression on stromal cells was measured.

Main Results:

• Etoposide treatment reduced the capacity of stromal cells to support lymphoid and myeloid cell proliferation.
• A consistent reduction in vascular cell adhesion molecule-1 (VCAM-1) on bone marrow stromal cells was observed after VP-16 exposure.
• These findings indicate chemotherapy-induced functional disruption of the bone marrow microenvironment.

Conclusions:

• Chemotherapeutic agents like etoposide can functionally impair bone marrow stromal cells.
• Damage to the bone marrow microenvironment by chemotherapy affects its ability to support hematopoiesis.
• Consideration of microenvironmental damage is crucial for optimizing patient recovery following hematopoietic transplantation.